[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![mupdatesbyscanx Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1926935883384553472.png) Market Updates by ScanX [@mupdatesbyscanx](/creator/twitter/mupdatesbyscanx) on x XXX followers
Created: 2025-07-18 12:57:32 UTC

Dr Reddys Laboratories (DRREDDY)
on NSE: 1257.50 (-0.44%)

FDA Inspection of Dr. Reddy's Srikakulam Facility Yields X Observations

View: Neutral

The USFDA completed an inspection of Dr. Reddy's Laboratories' formulations manufacturing facility in Srikakulam, Andhra Pradesh, from July XX to July 18, 2025. The inspection, which included both GMP and Pre-Approval assessments, resulted in a Form XXX with seven observations. Dr. Reddy's has committed to addressing these issues within the stipulated timeline. The company's response and ability to resolve these observations will be crucial for maintaining its standing with the USFDA and ensuring continued operations at the Srikakulam facility.

Read more:

#Stocks #Market #DRREDDY

![](https://pbs.twimg.com/media/GwJD3iIXwAAUROh.jpg)

XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946192613574647814/c:line.svg)

**Related Topics**
[$drreddyns](/topic/$drreddyns)
[dr reddys](/topic/dr-reddys)

[Post Link](https://x.com/mupdatesbyscanx/status/1946192613574647814)